Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

SANUWAVE Health (SNWV) Common Equity (2023 - 2025)

SANUWAVE Health (SNWV) has disclosed Common Equity for 9 consecutive years, with -$2.9 million as the latest value for Q3 2025.

  • On a quarterly basis, Common Equity rose 95.14% to -$2.9 million in Q3 2025 year-over-year; TTM through Sep 2025 was -$2.9 million, a 95.14% increase, with the full-year FY2024 number at -$12.7 million, up 70.55% from a year prior.
  • Common Equity was -$2.9 million for Q3 2025 at SANUWAVE Health, up from -$14.8 million in the prior quarter.
  • In the past five years, Common Equity ranged from a high of -$2.9 million in Q3 2025 to a low of -$66.0 million in Q3 2023.
  • A 3-year average of -$38.1 million and a median of -$43.2 million in 2023 define the central range for Common Equity.
  • Peak YoY movement for Common Equity: rose 8.63% in 2024, then soared 95.14% in 2025.
  • SANUWAVE Health's Common Equity stood at -$43.2 million in 2023, then skyrocketed by 70.55% to -$12.7 million in 2024, then soared by 76.95% to -$2.9 million in 2025.
  • Per Business Quant, the three most recent readings for SNWV's Common Equity are -$2.9 million (Q3 2025), -$14.8 million (Q2 2025), and -$17.3 million (Q1 2025).